Slayden, R A <br/><br/>
Isoniazid affects multiple components of the type II fatty acid synthase system of Mycobacterium tuberculosis.  [electronic resource] 

 -  Molecular microbiology  Nov 2000 
 - 514-25 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0950-382X 
<br/><br/><label>Standard No.: </label>10.1046/j.1365-2958.2000.02145.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>3-Oxoacyl-(Acyl-Carrier-Protein) Synthase--antagonists & inhibitors<br/>Acetyltransferases--antagonists & inhibitors<br/>Anti-Bacterial Agents--pharmacology<br/>Anti-Infective Agents, Local--pharmacology<br/>Antitubercular Agents--pharmacology<br/>Bacterial Proteins<br/>Drug Resistance, Microbial--genetics<br/>Enzyme Inhibitors--pharmacology<br/>Fatty Acid Synthase, Type II<br/>Humans<br/>Isoniazid--pharmacology<br/>Lipids--biosynthesis<br/>Microbial Sensitivity Tests<br/>Multienzyme Complexes--antagonists & inhibitors<br/>Mycobacterium smegmatis--drug effects<br/>Mycobacterium tuberculosis--drug effects<br/>Operon<br/>Oxidoreductases--antagonists & inhibitors<br/>Thiophenes--pharmacology<br/>Triclosan--pharmacology